-
1Academic Journal
المؤلفون: Sad , Elis Pinheiro, Landim, Maria Teresa de Oliveira Paes, Santos , Luiz Felipe Duarte Dos, Arlota , Fernanda Bortoli, Melo , Igor Barreto, Pires , Vivian Saeger, Dias, Rogério Belício, Simon, Mariana Saloum, Almeida, Rayana Hellen Gamosa, Fontana , Isabela Meneses de Morais, Silva , Paloma Encinas Beramendi, Paulino , Luciano Pinto, Franco, Natália Almeida Pinheiro, Brito , Ogi Janderson Antunes de Castro, Dias , Mariana Oliveira, Pinho, Victoria Alves, Badini , Rômulo Rodrigues, Nascimento , Alexandre Augusto de Sousa
المصدر: Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 3 (2024): BJIHS QUALIS B3; 278-292 ; Vol. 6 Núm. 3 (2024): BJIHS QUALIS B3; 278-292 ; v. 6 n. 3 (2024): BJIHS QUALIS B3; 278-292 ; 2674-8169
مصطلحات موضوعية: agonista do receptor GLP-1, antidiabéticos, atenção básica, custo-efetividade, Diabetes Mellitus tipo 2, Semaglutida, GLP-1 receptor agonist, antidiabetics, basic care, cost-effectiveness, Type 2 Diabetes Mellitus, Semaglutide
وصف الملف: application/pdf
Relation: https://bjihs.emnuvens.com.br/bjihs/article/view/1604/1785; https://bjihs.emnuvens.com.br/bjihs/article/view/1604